Anemia, Refractory, with Excess of Blasts [clinicaltrials_resource:4726362312e14a6cacc6e776efd35c7f]
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [clinicaltrials:NCT00005064]Tipifarnib in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00005845]Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [clinicaltrials:NCT00005942]BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [clinicaltrials:NCT00006213]Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [clinicaltrials:NCT00008177]Thalidomide in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00015990]Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies [clinicaltrials:NCT00038051]clinicaltrials:NCT00046930clinicaltrials:NCT00052520CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [clinicaltrials:NCT00084916]Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [clinicaltrials:NCT00087204]Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission [clinicaltrials:NCT00093470]XK469R in Treating Patients With Refractory Hematologic Cancer [clinicaltrials:NCT00095797]clinicaltrials:NCT00096122Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes [clinicaltrials:NCT00098423]SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [clinicaltrials:NCT00098826]clinicaltrials:NCT00104962Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00119366]clinicaltrials:NCT00121303Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T [clinicaltrials:NCT00209833]Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia [clinicaltrials:NCT00278330]A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [clinicaltrials:NCT00343798]A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. [clinicaltrials:NCT00363025]Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [clinicaltrials:NCT00392353]Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00397813]MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [clinicaltrials:NCT00462605]Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer [clinicaltrials:NCT00540995]Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome [clinicaltrials:NCT00589316]Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease [clinicaltrials:NCT00719888]Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant [clinicaltrials:NCT00796068]clinicaltrials:NCT00809250Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [clinicaltrials:NCT00988715]clinicaltrials:NCT01012492Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm [clinicaltrials:NCT01101880]Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT01146210]T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies [clinicaltrials:NCT01163201]clinicaltrials:NCT01165996Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT01168219]Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies [clinicaltrials:NCT01175785]
condition browse [clinicaltrials_vocabulary:condition-browse]
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [clinicaltrials:NCT00005064]Tipifarnib in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00005845]Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [clinicaltrials:NCT00005942]BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [clinicaltrials:NCT00006213]Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [clinicaltrials:NCT00008177]Thalidomide in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00015990]Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies [clinicaltrials:NCT00038051]clinicaltrials:NCT00046930clinicaltrials:NCT00052520CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [clinicaltrials:NCT00084916]Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [clinicaltrials:NCT00087204]Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission [clinicaltrials:NCT00093470]XK469R in Treating Patients With Refractory Hematologic Cancer [clinicaltrials:NCT00095797]clinicaltrials:NCT00096122Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes [clinicaltrials:NCT00098423]SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [clinicaltrials:NCT00098826]clinicaltrials:NCT00104962Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00119366]clinicaltrials:NCT00121303Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T [clinicaltrials:NCT00209833]Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia [clinicaltrials:NCT00278330]A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [clinicaltrials:NCT00343798]A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. [clinicaltrials:NCT00363025]Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [clinicaltrials:NCT00392353]Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00397813]MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [clinicaltrials:NCT00462605]Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer [clinicaltrials:NCT00540995]Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome [clinicaltrials:NCT00589316]Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease [clinicaltrials:NCT00719888]Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant [clinicaltrials:NCT00796068]clinicaltrials:NCT00809250Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [clinicaltrials:NCT00988715]clinicaltrials:NCT01012492Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm [clinicaltrials:NCT01101880]Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT01146210]T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies [clinicaltrials:NCT01163201]clinicaltrials:NCT01165996Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT01168219]Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies [clinicaltrials:NCT01175785]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Anemia, Refractory, with Excess of Blasts [clinicaltrials_resource:4726362312e14a6cacc6e776efd35c7f]
Bio2RDF identifier
4726362312e14a6cacc6e776efd35c7f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4726362312e14a6cacc6e776efd35c7f
identifier
clinicaltrials_resource:4726362312e14a6cacc6e776efd35c7f
title
Anemia, Refractory, with Excess of Blasts
@en
type
label
Anemia, Refractory, with Exces ...... 6362312e14a6cacc6e776efd35c7f]
@en
Anemia, Refractory, with Excess of Blasts